If you have been reading about regulatory status and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
The process for class 1 inteins begins with an N-O or N-S shift when the side chain of the first residue (a serine, threonine, or cysteine) of the intein portion of the precursor protein nucleophilically attacks the peptide bond of the residue immediately upstream (that is, the final residue of the N-extein) to form a linear ester (or thioester) intermediate. A transesterification occurs when the side chain of the first residue of the C-extein attacks the newly formed (thio)ester to free the N-terminal end of the intein. This forms a branched intermediate in which the N-extein and C-extein are attached, albeit not through a peptide bond. The last residue of the intein is always an asparagine (Asn), and the amide nitrogen atom of this side chain cleaves apart the peptide bond between the intein and the C-extein, resulting in a free intein segment with a terminal cyclic imide. Finally, the free amino group of the C-extein now attacks the (thio)ester linking the N- and C-exteins together. An O-N or S-N shift produces a peptide bond and the functional, ligated protein. Class 2 inteins have no nucleophilic first side chain, only an alanine. Instead, the reaction starts directly with a nucleophilic displacement, with the first residue of the C-extein attacking the peptide carboxyl on the final residue of the N-extein. The rest proceeds as usual, starting with Asn turning into a cyclic imide. Class 3 inteins have no nucleophilic first side chain, only an alanine, yet they have an internal noncontiguous "WCT" motif.
== Transformation of substrate == Substrate transformation involves the transformation of a specific compound into another, such as in the case of phenylacetylcarbinol, and steroid biotransformation, or the transformation of a raw material into a finished product, in the case of food fermentations and sewage treatment.
The FR Yugoslavia had more demographic variety than most other European countries. According to the 1992 census, the Federal Republic had 10,394,026 inhabitants. The three largest named nationalities were Serbs (6,504,048 inhabitants, or 62.6%), Albanians (1,714,768 inhabitants, or 16.5%), and Montenegrins (519,766 inhabitants, or 5%). The country also had significant populations of Hungarians, ethnic Yugoslavs, ethnic Muslims, Romani, Croats, Bulgarians, Macedonians, Romanians and Vlachs, and others (under 1%). Most of the ethnic diversity was situated in the autonomous provinces of Kosovo and Vojvodina, where smaller numbers of other minority groups could be found. The large Albanian population was chiefly concentrated in Kosovo, with smaller populations in the Preševo Valley, and in the Ulcinj municipality in Montenegro. The Muslim (Slavic Muslims, including Bosniaks and Gorani) population lived mostly in the federal border region (mainly Novi Pazar in Serbia, and Rožaje in Montenegro). The Montenegrin population at the time often considered themselves to be Serbs.
Sources: en.wikipedia.org
Operating a CH station was a manpower-intensive situation, with an operator in the transmitter hut, an operator and assistant in the receiver hut, and as many as six assistants in the receiver hut operating the plotters, calculators and telephone systems. In order to provide 24-hour service, multiple crews were needed, along with a number of service and support personnel. This was then multiplied by the reporting hierarchy, which required similar numbers of WAAFs at each level of the Dowding system hierarchy. Plotting the angle of the target was a simple process of taking the gonio reading and setting a rotating straightedge to that value. The problem was determining where along that straightedge the target lay; the radar measured the slant range straight-line distance to the target, not the distance over the ground. That distance was affected by the target's altitude, which had to be determined by taking the somewhat time-consuming altitude measurements. Additionally, that altitude was affected by the range, due to the curvature of the Earth, as well as any imperfections in the local environment, which caused the lobes to have different measurements depending on the target angle. As no small part of the manpower required was dedicated to calculation and plotting, a great reduction could be made by using as much automation as possible. This started with the use of various mechanical aids; these were eventually replaced by the fruit machine, an electromechanical analogue computer of some complexity. It replicated all of these devices and tables in electrical form.
== Education and career == Wickramasinghe studied at Royal College, Colombo, the University of Ceylon (where he graduated in 1960 with a BSc First Class Honours in mathematics), and at Trinity College and Jesus College, Cambridge, where he obtained his PhD and ScD degrees. Following his education, Wickramasinghe was a Fellow of Jesus College, Cambridge from 1963 to 1973, then became professor of applied mathematics and astronomy at University College Cardiff. Wickramasinghe was a consultant and advisor to the President of Sri Lanka from 1982 to 1984, and played a key role in founding the Institute of Fundamental Studies in Sri Lanka. After fifteen years at University College Cardiff, Wickramasinghe took an equivalent position in the University of Cardiff, a post he held from 1990 until 2006. After retirement in 2006, he incubated the Cardiff Center for Astrobiology as a special project reporting to the president of the university. In 2011 the project closed down, losing its funding in a series of UK educational cut backs. After this event, Wickramasinghe was offered the opportunity to move to the University of Buckingham as Director of the Buckingham Centre for Astrobiology, University of Buckingham where he has been since 2011. He maintains his part-time position as a UK Professor at Cardiff University. In 2015 he was elected Visiting scholar, Churchill College, Cambridge, England for 2015 and 2016.
== Awards == The society sponsors several awards including the Curt Brunnée Award for achievements in instrumentation by a scientist under 45 years of age, the Thomson Medal Award for achievements in mass spectrometry, as well as travel awards and student paper awards:
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.